News

A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...
Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...
Pfizer offers a dividend yield over 7%, but it's payout probably won't rise very fast in the decade ahead. Investors seeking ...
Legal and ethics experts said those business entanglements raise concerns about conflicting interests for an aspiring surgeon ...
SINGAPORE—China is racing toward economic self-sufficiency by weaning itself off American technology. But it has made a ...
New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, “significantly reduced” breast tissue cell growth, which is a major indicator of cancer ...
A team of Australian scientists has developed a novel method to reveal hidden HIV in white blood cells ...
GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global presence. GCCPL provides customized, technology-driven healthcare solutions to meet the evolving needs of today’s market ...
Helgi Kormaksson Joins CTS Executive Team SAN FRANCISCO, CA / ACCESS Newswire / June 6, 2025 / CTS is excited to announce that Helgi Kormaksson has joined the company as Chief Design Officer. Helgi ...